Quanterix Corporation (QTRX)
NASDAQ: QTRX · IEX Real-Time Price · USD
16.88
-0.05 (-0.27%)
May 3, 2024, 2:10 PM EDT - Market open
Quanterix Revenue
In the year 2023, Quanterix had annual revenue of $122.37M with 15.96% growth. Revenue in the quarter ending December 31, 2023 was $31.55M with 22.17% year-over-year growth.
Revenue (ttm)
$122.37M
Revenue Growth
+15.96%
P/S Ratio
5.29
Revenue / Employee
$277,478
Employees
441
Market Cap
642.93M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 122.37M | 16.85M | 15.96% |
Dec 31, 2022 | 105.52M | -5.03M | -4.55% |
Dec 31, 2021 | 110.56M | 24.18M | 27.99% |
Dec 31, 2020 | 86.38M | 29.64M | 52.25% |
Dec 31, 2019 | 56.73M | 19.10M | 50.76% |
Dec 31, 2018 | 37.63M | 14.76M | 64.52% |
Dec 31, 2017 | 22.87M | 5.29M | 30.08% |
Dec 31, 2016 | 17.59M | 5.41M | 44.38% |
Dec 31, 2015 | 12.18M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cross Country Healthcare | 2.02B |
Novavax | 983.71M |
The Pennant Group | 544.89M |
Fulgent Genetics | 289.21M |
SIGA Technologies | 139.92M |
Zymeworks | 76.01M |
Exscientia | 25.42M |
Dianthus Therapeutics | 2.83M |
QTRX News
- 3 days ago - Quanterix To Report First Quarter 2024 Financial Results - Business Wire
- 6 weeks ago - Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer's Disease Testing Infrastructure - Business Wire
- 2 months ago - Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimer's Disease - Business Wire
- 2 months ago - Quanterix Releases Operating Results for Fourth Quarter and Full Year 2023 - Business Wire
- 2 months ago - Quanterix Reschedules Q4 and Full Year 2023 Earnings Conference Call; Reaffirms 2023 Guidance - Business Wire
- 2 months ago - Quanterix Announces First Collaborations with Five Health Networks to Aid the Diagnosis and Clinical Management of Individuals with Alzheimer's Disease - Business Wire
- 2 months ago - Quanterix to Present at Cowen's 44th Annual Health Care Conference - Business Wire
- 2 months ago - Quanterix Fourth Quarter Earnings and Full Year 2023 Financial Results Conference Call - Business Wire